Misook Yu

Array ( [id] => 588381 [patent_doc_number] => 07435554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)' [patent_app_type] => utility [patent_app_number] => 10/954037 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 17760 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435554.pdf [firstpage_image] =>[orig_patent_app_number] => 10954037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199960 [patent_doc_number] => 20050042201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Histidine-rich glycoprotein' [patent_app_type] => utility [patent_app_number] => 10/951059 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13095 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042201.pdf [firstpage_image] =>[orig_patent_app_number] => 10951059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7154274 [patent_doc_number] => 20050026232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Antibodies specific for phosphatase subunit of LAR' [patent_app_type] => utility [patent_app_number] => 10/945647 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15426 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026232.pdf [firstpage_image] =>[orig_patent_app_number] => 10945647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938993 [patent_doc_number] => 20050112556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens' [patent_app_type] => utility [patent_app_number] => 10/940559 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 19123 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112556.pdf [firstpage_image] =>[orig_patent_app_number] => 10940559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188008 [patent_doc_number] => 20070166316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Tumor-derived biological antigen presenting particles' [patent_app_type] => utility [patent_app_number] => 10/528082 [patent_app_country] => US [patent_app_date] => 2004-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7211 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166316.pdf [firstpage_image] =>[orig_patent_app_number] => 10528082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971232 [patent_doc_number] => 20050036942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Anti-tumor antibody compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/937046 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 39628 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20050036942.pdf [firstpage_image] =>[orig_patent_app_number] => 10937046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252111 [patent_doc_number] => 20050074797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'FHIT proteins and nucleic acids and methods based thereon' [patent_app_type] => utility [patent_app_number] => 10/913228 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40734 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074797.pdf [firstpage_image] =>[orig_patent_app_number] => 10913228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211897 [patent_doc_number] => 20050054056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Variant cell surface molecule associated with cancer' [patent_app_type] => utility [patent_app_number] => 10/912922 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7856 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054056.pdf [firstpage_image] =>[orig_patent_app_number] => 10912922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122086 [patent_doc_number] => 07709600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Interaction between the VHL tumor suppressor and hypoxia inducible factor, and assay methods relating thereto' [patent_app_type] => utility [patent_app_number] => 10/901583 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14486 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709600.pdf [firstpage_image] =>[orig_patent_app_number] => 10901583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6917692 [patent_doc_number] => 20050095253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Tumour associated antigen 791Tgp72' [patent_app_type] => utility [patent_app_number] => 10/901601 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12249 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095253.pdf [firstpage_image] =>[orig_patent_app_number] => 10901601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952151 [patent_doc_number] => 20050227245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Reagents and methods for identifying and modulating expression of genes regulated by retinoids' [patent_app_type] => utility [patent_app_number] => 10/891991 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8893 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227245.pdf [firstpage_image] =>[orig_patent_app_number] => 10891991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423186 [patent_doc_number] => 20040265316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'FHIT proteins and nucleic acids and methods based thereon' [patent_app_type] => new [patent_app_number] => 10/889934 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40715 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265316.pdf [firstpage_image] =>[orig_patent_app_number] => 10889934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010796 [patent_doc_number] => 20050064512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Emitter-binding peptides that produce a change in the spectral emission properties of the emitter' [patent_app_type] => utility [patent_app_number] => 10/887231 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7265 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064512.pdf [firstpage_image] =>[orig_patent_app_number] => 10887231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206060 [patent_doc_number] => 20050043224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy' [patent_app_type] => utility [patent_app_number] => 10/881028 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14036 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043224.pdf [firstpage_image] =>[orig_patent_app_number] => 10881028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7419616 [patent_doc_number] => 20040228925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Method for inducing an anti-tumor and anti-cachexia immune response in mammals' [patent_app_type] => new [patent_app_number] => 10/871340 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5901 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228925.pdf [firstpage_image] =>[orig_patent_app_number] => 10871340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5084897 [patent_doc_number] => 20070274948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Methods of Therapy for Chronic Lymphocytic Leukemia' [patent_app_type] => utility [patent_app_number] => 10/566410 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26114 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274948.pdf [firstpage_image] =>[orig_patent_app_number] => 10566410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101446 [patent_doc_number] => 07727533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Serpentine transmembrane antigens expressed in human cancers and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/857785 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 44 [patent_no_of_words] => 22204 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727533.pdf [firstpage_image] =>[orig_patent_app_number] => 10857785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983235 [patent_doc_number] => 20050153305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Novel proteins and nucleic acids encoding same' [patent_app_type] => utility [patent_app_number] => 10/851438 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51216 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153305.pdf [firstpage_image] =>[orig_patent_app_number] => 10851438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177685 [patent_doc_number] => 07655393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Adoptive immune cells for tumor vaccines' [patent_app_type] => utility [patent_app_number] => 11/579280 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8741 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655393.pdf [firstpage_image] =>[orig_patent_app_number] => 11579280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422151 [patent_doc_number] => 20040229267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Tumor suppressor pathway in C. elegans' [patent_app_type] => new [patent_app_number] => 10/839896 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17654 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229267.pdf [firstpage_image] =>[orig_patent_app_number] => 10839896 [rel_patent_id] =>[rel_patent_doc_number] =>)